Unified, holistic medical data collection and analysis platform

Projektinformationen

UNITY

ID Finanzhilfevereinbarung: 868266

DOI

10.3030/868266

Projekt abgeschlossen

EK-Unterschriftsdatum 30 April 2019

Startdatum 1 Mai 2019

Enddatum 31 August 2019

Finanziert unter

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Gesamtkosten

€ 71 429,00

EU-Beitrag

€ 50 000,00

Koordiniert durch

RAYLYTIC GMBH
Germany

Periodic Reporting for period 1 - UNITY (Unified, holistic medical data collection and analysis platform)

Berichtszeitraum: 2019-05-01 bis 2019-08-31

Zusammenfassung vom Kontext und den Gesamtzielen des Projekts

UNITY is a cloud-based platform that combines modules for clinical trial management, electronic data capture of patient reported and treatment outcomes, and semi-automated medical image analysis. Its image analysis module can assess the performance of orthopedic implants and detect and quantify musculoskeletal conditions with an accuracy superior to human radiologists. However, we are constrained by our semi-automatic way of processing medical images. Once we develop a fully automated platform, it will be able to perform in seconds tasks that now may take up to one week. With individual modules already on the market and a prototype of the UNITY platform in place, our technology is at TRL 6.

Arbeit, die ab Beginn des Projekts bis zum Ende des durch den Bericht erfassten Berichtszeitraums geleistet wurde, und die wichtigsten bis dahin erzielten Ergebnisse

The feasibility study was conducted to validate our idea of deploying UNITY as fully automated platform for assessment of musculoskeletal conditions. We assessed the technical requirements and prepared a work plan that served as basis for estimating the resources and time needed to complete the project. We also performed a comprehensive analysis of the market, including competition, challenges and trends, freedom to operate and size of the market opportunity. Finally, we developed a business plan for its commercialization; it outlines the strategy to grow our market share and customer base, as well as tentative pricing and revenue models.

Fortschritte, die über den aktuellen Stand der Technik hinausgehen und voraussichtliche potenzielle Auswirkungen (einschließlich der bis dato erzielten sozioökonomischen Auswirkungen und weiter gefassten gesellschaftlichen Auswirkungen des Projekts)

The expected impact of the Accelerator grant to our company is very high: we project revenues growing up to €26.4 million in the first 5 commercialization years. We also forecast a growth from 25 to 54 employees and a return on investment of 5.7 by the end of 5th commercialization year.
Our platform offers a unique opportunity for more accurate, personalized treatments. This can result in savings and optimization of workflows for healthcare providers and medtech companies, currently challenged with increasing regulatory constraints. It can also improve the quality of care benefiting both, the patients and the economy.

image-1.png